Unibest 优贝德
← Back to patent-cliff list

CAS 2044680-93-3

(1aR,2S,3S,5S,6S,10S,10aS,11aS)-10-[(Benzyloxy)methoxy]-5-hydroxy-2,10a,12,12-tetramethyl-3,4,5,6,8,9,10,10a,11,11a-decahydro-2H-2,3-epoxy-1a,5-methanobenzo[4,5]cyclodeca[1,2-b]oxiren-6-yl benzoate

Codes:(XX)101438-60-b

Application context (from source-drug indications)

乳腺癌Paclitaxel/Encequidar mesylate腺癌Paclitaxel/Encequidar mesylate血管肉瘤Paclitaxel/Encequidar mesylate实体瘤Paclitaxel/Encequidar mesylate

Source drugs (routes using this intermediate)

DrugTierExpiry
Paclitaxel/Encequidar mesylatePaclitaxel/Encequidar mesylateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.